![](https://siific.co.jp/wp-content/uploads/2024/08/スクリーンショット-2024-08-28-6.11.08.png)
KAZU UMEDA
Founding Partner
Kazu Umeda, Representative and Founding Partner of SIIF Impact Capital (SIIFIC), brings a wealth of experience in the investment realm, particularly in negotiating with large corporations, startup creation, M&A and IPO for portfolio companies during his tenure at m3, INCJ and Japan Asia Investment. Kazu understands that for startups to thrive, they cannot rely solely on financial success to compete with established enterprises and the market. Recognizing the importance of impact measurement and management alongside with visualizing the value creation process, he firmly believes that startups must garner societal support in order to scale. With his deep operational insights, Kazu strives to maximize returns and spearhead the growth of innovative startups.
President and CEO, M3i inc.
Venture Investment Partner, Business development group, M3, Inc.
Vice President, The Innovation Network Corporation of Japan (INCJ)
Head of CEO’s office, Tokyo, Japan Asia Investment Co. Ltd
President, JAIC Asia Holdings Pte Ltd, Singapore
President, JAIC ASIA Capital Pte Ltd, Singapore
President, PT JAIC Indonesia, Jakarta
President, JAIC (Thailand) Co., Ltd, Bangkok
Investment Manager, JAIC America, Inc., Palo Alto, California, USA
Kazu holds a B.Sc. and M.Sc. in Life Sciences from Tokyo University of Pharmacy and Life Sciences.
![](https://siific.co.jp/wp-content/uploads/2024/08/スクリーンショット-2024-08-28-6.10.53.png)
REIRI MIURA
Founding Partner
Reiri Miura, Representative and Founding Partner of SIIF Impact Capital (SIIFIC), brings a wealth of experience in building businesses of real value, particularly in healthcare industry. Reiri joined Japan Social Innovation and Investment Foundation (SIIF) in 2022 to establish SIIF Impact Capital. Prior to joining SIIF, she held positions including Head of Corporate Strategy at TRYT, Healthcare Technologies, Taiho Pharmaceuticals; Investment & Business Development Manager at Mitsubishi Corporation.
Reiri holds a B.Sc. in Biological Sciences from Durham University, a M.Sc. in Molecular Embryology from University of Tokyo, a M.MA. in Health Policy from Tokyo Medical and Dental University, a Certificate in Creating Shared Value from Harvard Business School and a Certificate in Impact Investing from Oxford Said Business School.